e-learning
resources
Glasgow 2004
Tuesday 07.09.2004
Pathobiological and clinical investigations in airway disorders
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Duration of smoking cessation and bronchial inflammation in COPD
T. S. Lapperre, J. B. Snoeck-Stroband, M. M. E. Gosman, T. Mauad, P. S. Hiemstra, N. H. T. Ten Hacken, W. Timens, D. S. Postma, P. J. Sterk, the GLUCOLD Study Group (Groningen & Leiden, Leiden, Groningen, The Netherlands)
Source:
Annual Congress 2004 - Pathobiological and clinical investigations in airway disorders
Session:
Pathobiological and clinical investigations in airway disorders
Session type:
Oral Presentation
Number:
2880
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
T. S. Lapperre, J. B. Snoeck-Stroband, M. M. E. Gosman, T. Mauad, P. S. Hiemstra, N. H. T. Ten Hacken, W. Timens, D. S. Postma, P. J. Sterk, the GLUCOLD Study Group (Groningen & Leiden, Leiden, Groningen, The Netherlands). Duration of smoking cessation and bronchial inflammation in COPD. Eur Respir J 2004; 24: Suppl. 48, 2880
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Effect of 1-year smoking cessation on airway inflammation in COPD and asymptomatic smokers
Source: Eur Respir J 2005; 26: 835-845
Year: 2005
Effects of one year smoking cessation on inflammation in induced sputum of smokers with and without COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 583s
Year: 2002
Effects of smoking cessation in COPD
Source: Annual Congress 2006 - Smoking and COPD: will it ever vanish into smoke?
Year: 2006
Airway mucosal inflammation in COPD is similar in smokers and ex-smokers: a pooled analysis
Source: Eur Respir J 2007; 30: 467-471
Year: 2007
COPD disease progression and airway inflammation: uncoupled by smoking cessation
Source: Eur Respir J 2005; 26: 764-766
Year: 2005
Effect of 1-year smoking cessation on matrix-metalloproteinases and their inhibitors in COPD
Source: Annual Congress 2006 - Cell biology of asthma and COPD
Year: 2006
COPD patients‘ response to smoking cessation
Source: Annual Congress 2005 - Smoking cessation in respiratory diseases: methods and results
Year: 2005
Airway inflammation persists after smoking cessation in chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2001; 18: Suppl. 33, 249s
Year: 2001
Smoking cessation by hospitalization yields a high rate of smoke abstinence in COPD-patients
Source: Annual Congress 2007 - Smoking and COPD
Year: 2007
Smoking habit and bronchial hyperresponsiveness in patients with COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 39s
Year: 2006
Recommendations for smoking cessation treatment in respiratory patients
Source: Annual Congress 2007 - PG15 - Difficult-to-treat asthma: dealing with smoker patients
Year: 2007
Nasal and bronchial inflammation markers in smokers before and after smoking cessation program
Source: Annual Congress 2005 - Smoking cessation in respiratory diseases: methods and results
Year: 2005
The impact of smoking cessation on respiratory symptoms, lung function, airway hyperresponsiveness and inflammation
Source: Eur Respir J 2004; 23: 464-476
Year: 2004
Are symptoms of chronic bronchitis and sputum inflammatory cell counts related to the duration of smoking cessation in COPD?
Source: Eur Respir J 2004; 24: Suppl. 48, 45s
Year: 2004
Acute effect of passive cigarette smoking on airway inflammation
Source: Eur Respir J 2005; 26: Suppl. 49, 129s
Year: 2005
Smoking cessation improves both direct and indirect airway hyperresponsiveness in COPD
Source: Eur Respir J 2004; 24: 391-396
Year: 2004
Effect of smoking status on bronchial b-cells in COPD
Source: Annual Congress 2009 - COPD and asthma - from the cell to the clinic
Year: 2009
Effects of smoking cessation on spirometry in mild to moderate COPD
Source: Virtual Congress 2020 – Smoking disease landscape: from inflammation to lung function and comorbidities
Year: 2020
“Lung age” – a motivational smoking cessation tool in smokers with chronic obstructive pulmonary disease
Source: International Congress 2018 – Tobacco use and cessation interventions in patients with respiratory, cardiovascular and mental health problems and other populations
Year: 2018
Smoking cessation for COPD
Source: Annual Congress 2009 - PG6 Core Curriculum Postgraduate Course: How to reduce the burden of COPD
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept